Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Publication|Articles|July 28, 2023
- July 2023
- Volume 89
- Issue 7
Pet Peeves — Brought To You By The Sassy Pharmacist
Advertisement
Impatient Patients
Calling from the drive-through to complain about how long they have been waiting.
Articles in this issue
about 3 years ago
Brain Health Watchabout 3 years ago
Interactive Case Studiesabout 3 years ago
Postnasal Dripabout 3 years ago
Expanding Tech-Check-Tech Will Move Pharmacy Into the Futureabout 3 years ago
Continuous Glucose Monitoring Technology Continues to Rapidly Expandabout 3 years ago
Promoting Medication Safety Improves Health Outcomesabout 3 years ago
Pharmacist Sues Former Employer, Alleges Employment Discriminationover 3 years ago
Do Pharmaceutical Brand Colors Affect Consumer Buying Decisions?Advertisement
Related to this article
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
A summer PCAC vote pushes 6 peptide families toward the 503A bulks list—but the FDA's decision is still pending.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5